Hitoshi Fujiwara
Kyoto Prefectural University, Kyoto Prefectural University of Medicine
Papers
6
Total Citations
59
H-Index
3
About
Hitoshi Fujiwara is a leading Japanese surgical oncologist whose research centers on minimally invasive approaches for esophageal and gastric cancers, with a particular focus on improving radical resection outcomes. His most impactful work, the 2019 study on the transmediastinal approach for esophageal squamous cell carcinoma (ESCC), has garnered 40 citations and represents a significant shift toward less invasive yet equally radical surgery for this aggressive disease, which is prevalent in Asia. Fujiwara has also pioneered comparative studies on robotic versus laparoscopic gastrectomy, demonstrating that robotic distal gastrectomy facilitates minimally invasive surgery for gastric cancer with potentially fewer complications. His research on postoperative complications is particularly notable: a 2023 study identified pancreatic fistula as the strongest predictor of poor prognosis among postoperative complications, while his 2024 work on intraoperative image analysis offers a novel method for risk assessment. Additionally, his investigations into liver dysfunction after gastric cancer surgery and the advantages of robotic surgery for rectal cancer—specifically regarding pelvic anatomy and urinary dysfunction—highlight his comprehensive approach to improving surgical outcomes. With a growing citation record and a focus on translating technical innovations into better patient prognoses, Fujiwara is establishing himself as a key figure in advancing minimally invasive oncologic surgery in Asia.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4
- 5
- 6